APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nanobody Discovery Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nanobody Discovery Service Industry Growth and Trends Forecast to 2032

4 March 2026110 pages

Choose your research edition.

Industry ResearchNanobody Discovery Service Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Nanobody Discovery Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Nanobody Discovery Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nanobody Discovery Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nanobody Discovery Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global Nanobody Discovery Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nanobody Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nanobody Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nanobody Discovery Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Nanobody Discovery Service market include Creative Biolabs, Curia, Sanofi, NanoTag Biotechnologies, Shanghai Medicilon Inc., Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., Yeasen Biotechnology（Shanghai）Co.,Ltd., Fortis Life Sciences and Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nanobody Discovery Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nanobody Discovery Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nanobody Discovery Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nanobody Discovery Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Nanobody Discovery Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nanobody Discovery Service Market by Company

Creative Biolabs

Curia

Sanofi

NanoTag Biotechnologies

Shanghai Medicilon Inc.

Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.

Yeasen Biotechnology（Shanghai）Co.,Ltd.

Fortis Life Sciences

Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.

Biointron Biological Inc.

SAFE Pharmaceutical Technology Co., Ltd.

Abterra Biosciences

Chengdu Apak Biotechnology Co., Ltd.

ICarTab Biomedical Co., Ltd.

Wuhan Daian Biotech Ltd

Nanobody Discovery Service Segment by Type

Screening and Development Services

Engineering and Optimization Services

Production and Expression Services

Other Services

Nanobody Discovery Service Segment by Application

Drug Discovery

Biological Engineering

Clinical Diagnosis

Immune Research

Others

Nanobody Discovery Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanobody Discovery Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nanobody Discovery Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanobody Discovery Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Nanobody Discovery Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Nanobody Discovery Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Nanobody Discovery Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Nanobody Discovery Service Market Share by Region (2021-2026) Table 4. Global Nanobody Discovery Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Nanobody Discovery Service Market Share by Region (2027-2032) Table 6. Global Nanobody Discovery Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Nanobody Discovery Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Nanobody Discovery Service Market Size Share by Type (2021-2026) Table 9. Global Nanobody Discovery Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Nanobody Discovery Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Nanobody Discovery Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Nanobody Discovery Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Nanobody Discovery Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Nanobody Discovery Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Nanobody Discovery Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Nanobody Discovery Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Nanobody Discovery Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Nanobody Discovery Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Nanobody Discovery Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Nanobody Discovery Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Nanobody Discovery Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Nanobody Discovery Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Nanobody Discovery Service Market Size Share by Application (2021-2026) Table 24. Global Nanobody Discovery Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Nanobody Discovery Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Nanobody Discovery Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Nanobody Discovery Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Nanobody Discovery Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Nanobody Discovery Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Nanobody Discovery Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Nanobody Discovery Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Nanobody Discovery Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Nanobody Discovery Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Nanobody Discovery Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Nanobody Discovery Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Nanobody Discovery Service Industry Trends Table 37. Nanobody Discovery Service Industry Drivers Table 38. Nanobody Discovery Service Industry Opportunities and Challenges Table 39. Nanobody Discovery Service Industry Restraints Table 40. Global Nanobody Discovery Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Nanobody Discovery Service Revenue Market Share by Company (2021-2026) Table 42. Global Nanobody Discovery Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Nanobody Discovery Service Key Company Headquarters & Area Served Table 44. Global Nanobody Discovery Service Company, Product Type & Application Table 45. Global Nanobody Discovery Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Nanobody Discovery Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Creative Biolabs Company Information Table 49. Creative Biolabs Business Overview Table 50. Creative Biolabs Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Creative Biolabs Nanobody Discovery Service Product Portfolio Table 52. Creative Biolabs Recent Development Table 53. Curia Company Information Table 54. Curia Business Overview Table 55. Curia Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Curia Nanobody Discovery Service Product Portfolio Table 57. Curia Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Nanobody Discovery Service Product Portfolio Table 62. Sanofi Recent Development Table 63. NanoTag Biotechnologies Company Information Table 64. NanoTag Biotechnologies Business Overview Table 65. NanoTag Biotechnologies Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio Table 67. NanoTag Biotechnologies Recent Development Table 68. Shanghai Medicilon Inc. Company Information Table 69. Shanghai Medicilon Inc. Business Overview Table 70. Shanghai Medicilon Inc. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio Table 72. Shanghai Medicilon Inc. Recent Development Table 73. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information Table 74. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview Table 75. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio Table 77. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development Table 78. Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information Table 79. Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview Table 80. Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio Table 82. Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Development Table 83. Fortis Life Sciences Company Information Table 84. Fortis Life Sciences Business Overview Table 85. Fortis Life Sciences Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Fortis Life Sciences Nanobody Discovery Service Product Portfolio Table 87. Fortis Life Sciences Recent Development Table 88. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information Table 89. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview Table 90. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio Table 92. Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Development Table 93. Biointron Biological Inc. Company Information Table 94. Biointron Biological Inc. Business Overview Table 95. Biointron Biological Inc. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Biointron Biological Inc. Nanobody Discovery Service Product Portfolio Table 97. Biointron Biological Inc. Recent Development Table 98. SAFE Pharmaceutical Technology Co., Ltd. Company Information Table 99. SAFE Pharmaceutical Technology Co., Ltd. Business Overview Table 100. SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio Table 102. SAFE Pharmaceutical Technology Co., Ltd. Recent Development Table 103. Abterra Biosciences Company Information Table 104. Abterra Biosciences Business Overview Table 105. Abterra Biosciences Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Abterra Biosciences Nanobody Discovery Service Product Portfolio Table 107. Abterra Biosciences Recent Development Table 108. Chengdu Apak Biotechnology Co., Ltd. Company Information Table 109. Chengdu Apak Biotechnology Co., Ltd. Business Overview Table 110. Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio Table 112. Chengdu Apak Biotechnology Co., Ltd. Recent Development Table 113. ICarTab Biomedical Co., Ltd. Company Information Table 114. ICarTab Biomedical Co., Ltd. Business Overview Table 115. ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio Table 117. ICarTab Biomedical Co., Ltd. Recent Development Table 118. Wuhan Daian Biotech Ltd Company Information Table 119. Wuhan Daian Biotech Ltd Business Overview Table 120. Wuhan Daian Biotech Ltd Nanobody Discovery Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio Table 122. Wuhan Daian Biotech Ltd Recent Development Table 123. North America Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Nanobody Discovery Service Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Nanobody Discovery Service Market Share by Country (2021-2026) Table 126. North America Nanobody Discovery Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Nanobody Discovery Service Market Share Forecast by Country (2027-2032) Table 128. Europe Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Europe Nanobody Discovery Service Market Size by Country (2021-2026) & (US$ Million) Table 130. Europe Nanobody Discovery Service Market Share by Country (2021-2026) Table 131. Europe Nanobody Discovery Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Europe Nanobody Discovery Service Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific Nanobody Discovery Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific Nanobody Discovery Service Market Share by Country (2021-2026) Table 136. Asia-Pacific Nanobody Discovery Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific Nanobody Discovery Service Market Share Forecast by Country (2027-2032) Table 138. Latin America Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Nanobody Discovery Service Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Nanobody Discovery Service Market Share by Country (2021-2026) Table 141. Latin America Nanobody Discovery Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Nanobody Discovery Service Market Share Forecast by Country (2027-2032) Table 143. Middle East & Africa Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Middle East & Africa Nanobody Discovery Service Market Size by Country (2021-2026) & (US$ Million) Table 145. Middle East & Africa Nanobody Discovery Service Market Share by Country (2021-2026) Table 146. Middle East & Africa Nanobody Discovery Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Middle East & Africa Nanobody Discovery Service Market Share Forecast by Country (2027-2032) Table 148. Research Programs/Design for This Report Table 149. Authors List of This Report Table 150. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Nanobody Discovery Service Product Image Figure 3. Global Nanobody Discovery Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Nanobody Discovery Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Nanobody Discovery Service Market Share by Region: 2025 VS 2032 Figure 6. Global Nanobody Discovery Service Market Share by Region (2021-2032) Figure 7. North America Nanobody Discovery Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Nanobody Discovery Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Nanobody Discovery Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Nanobody Discovery Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Nanobody Discovery Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Screening and Development Services Image Figure 13. Global Screening and Development Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Engineering and Optimization Services Image Figure 15. Global Engineering and Optimization Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Production and Expression Services Image Figure 17. Global Production and Expression Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Other Services Image Figure 19. Global Other Services Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Nanobody Discovery Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Nanobody Discovery Service Market Share by Type 2025 VS 2032 Figure 22. North America Nanobody Discovery Service Market Size Share by Type (2021-2032) Figure 23. Europe Nanobody Discovery Service Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Nanobody Discovery Service Market Size Share by Type (2021-2032) Figure 25. Latin America Nanobody Discovery Service Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Nanobody Discovery Service Market Size Share by Type (2021-2032) Figure 27. Drug Discovery Image Figure 28. Global Drug Discovery Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Biological Engineering Image Figure 30. Global Biological Engineering Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Clinical Diagnosis Image Figure 32. Global Clinical Diagnosis Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Immune Research Image Figure 34. Global Immune Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Others Image Figure 36. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Global Nanobody Discovery Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Nanobody Discovery Service Market Share by Application 2025 VS 2032 Figure 39. North America Nanobody Discovery Service Market Size Share by Application (2021-2032) Figure 40. Europe Nanobody Discovery Service Market Size Share by Application (2021-2032) Figure 41. Asia-Pacific Nanobody Discovery Service Market Size Share by Application (2021-2032) Figure 42. Latin America Nanobody Discovery Service Market Size Share by Application (2021-2032) Figure 43. Middle East and Africa Nanobody Discovery Service Market Size Share by Application (2021-2032) Figure 44. Global Top 5 and 10 Nanobody Discovery Service Players Market Share by Revenue in 2025 Figure 45. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 46. North America Nanobody Discovery Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. North America Nanobody Discovery Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. North America Nanobody Discovery Service Market Share by Country (2021-2032) Figure 49. Europe Nanobody Discovery Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nanobody Discovery Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Nanobody Discovery Service Market Share by Country (2021-2032) Figure 52. Asia-Pacific Nanobody Discovery Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Asia-Pacific Nanobody Discovery Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Asia-Pacific Nanobody Discovery Service Market Share by Country (2021-2032) Figure 55. Latin America Nanobody Discovery Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nanobody Discovery Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nanobody Discovery Service Market Share by Country (2021-2032) Figure 58. Middle East & Africa Nanobody Discovery Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Middle East & Africa Nanobody Discovery Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Middle East & Africa Nanobody Discovery Service Market Share by Country (2021-2032) Figure 61. Years Considered Figure 62. Research Process Figure 63. Key Executives Interviewed

Scope & coverage.

Types
  • Screening and Development Services
  • Engineering and Optimization Services
  • Production and Expression Services
  • Other Services
Applications
  • Drug Discovery
  • Biological Engineering
  • Clinical Diagnosis
  • Immune Research
  • Others
Companies covered
  • Creative Biolabs
  • Curia
  • Sanofi
  • NanoTag Biotechnologies
  • Shanghai Medicilon Inc.
  • Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  • Yeasen Biotechnology（Shanghai）Co.,Ltd.
  • Fortis Life Sciences
  • Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  • Biointron Biological Inc.
  • SAFE Pharmaceutical Technology Co., Ltd.
  • Abterra Biosciences
  • Chengdu Apak Biotechnology Co., Ltd.
  • ICarTab Biomedical Co., Ltd.
  • Wuhan Daian Biotech Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Nanobody Discovery Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Nanobody Discovery Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Nanobody Discovery Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Nanobody Discovery Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Nanobody Discovery Service Market Size (2021-2032)
  8. 1.5.1 North America Nanobody Discovery Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Nanobody Discovery Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Nanobody Discovery Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Nanobody Discovery Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Nanobody Discovery Service Market Size Growth Rate (2021-2032)
2 Nanobody Discovery Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Screening and Development Services
  3. 2.1.2 Engineering and Optimization Services
  4. 2.1.3 Production and Expression Services
  5. 2.1.4 Other Services
  6. 2.2 Global Nanobody Discovery Service Market Size by Type
  7. 2.2.1 Global Nanobody Discovery Service Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Nanobody Discovery Service Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Nanobody Discovery Service Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Nanobody Discovery Service Market Size by Regions
  11. 2.3.1 North America Nanobody Discovery Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Nanobody Discovery Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Nanobody Discovery Service Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Nanobody Discovery Service Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Nanobody Discovery Service Market Size Breakdown by Type (2021-2026)
3 Nanobody Discovery Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Drug Discovery
  3. 3.1.2 Biological Engineering
  4. 3.1.3 Clinical Diagnosis
  5. 3.1.4 Immune Research
  6. 3.1.5 Others
  7. 3.2 Global Nanobody Discovery Service Market Size by Application
  8. 3.2.1 Global Nanobody Discovery Service Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Nanobody Discovery Service Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Nanobody Discovery Service Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Nanobody Discovery Service Market Size by Regions
  12. 3.3.1 North America Nanobody Discovery Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Nanobody Discovery Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Nanobody Discovery Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Nanobody Discovery Service Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Nanobody Discovery Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Nanobody Discovery Service Industry Trends
  2. 4.2 Nanobody Discovery Service Industry Drivers
  3. 4.3 Nanobody Discovery Service Industry Opportunities and Challenges
  4. 4.4 Nanobody Discovery Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Nanobody Discovery Service Revenue (2021-2026)
  2. 5.2 Global Nanobody Discovery Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Nanobody Discovery Service Key Company Headquarters & Area Served
  4. 5.4 Global Nanobody Discovery Service Company, Product Type & Application
  5. 5.5 Global Nanobody Discovery Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Nanobody Discovery Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Nanobody Discovery Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Nanobody Discovery Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Creative Biolabs
  2. 6.1.1 Creative Biolabs Company Information
  3. 6.1.2 Creative Biolabs Business Overview
  4. 6.1.3 Creative Biolabs Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Creative Biolabs Nanobody Discovery Service Product Portfolio
  6. 6.1.5 Creative Biolabs Recent Developments
  7. 6.2 Curia
  8. 6.2.1 Curia Company Information
  9. 6.2.2 Curia Business Overview
  10. 6.2.3 Curia Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Curia Nanobody Discovery Service Product Portfolio
  12. 6.2.5 Curia Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Nanobody Discovery Service Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 NanoTag Biotechnologies
  20. 6.4.1 NanoTag Biotechnologies Company Information
  21. 6.4.2 NanoTag Biotechnologies Business Overview
  22. 6.4.3 NanoTag Biotechnologies Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 NanoTag Biotechnologies Nanobody Discovery Service Product Portfolio
  24. 6.4.5 NanoTag Biotechnologies Recent Developments
  25. 6.5 Shanghai Medicilon Inc.
  26. 6.5.1 Shanghai Medicilon Inc. Company Information
  27. 6.5.2 Shanghai Medicilon Inc. Business Overview
  28. 6.5.3 Shanghai Medicilon Inc. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Medicilon Inc. Nanobody Discovery Service Product Portfolio
  30. 6.5.5 Shanghai Medicilon Inc. Recent Developments
  31. 6.6 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  32. 6.6.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
  33. 6.6.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
  34. 6.6.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
  36. 6.6.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
  37. 6.7 Yeasen Biotechnology（Shanghai）Co.,Ltd.
  38. 6.7.1 Yeasen Biotechnology（Shanghai）Co.,Ltd. Company Information
  39. 6.7.2 Yeasen Biotechnology（Shanghai）Co.,Ltd. Business Overview
  40. 6.7.3 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Yeasen Biotechnology（Shanghai）Co.,Ltd. Nanobody Discovery Service Product Portfolio
  42. 6.7.5 Yeasen Biotechnology（Shanghai）Co.,Ltd. Recent Developments
  43. 6.8 Fortis Life Sciences
  44. 6.8.1 Fortis Life Sciences Company Information
  45. 6.8.2 Fortis Life Sciences Business Overview
  46. 6.8.3 Fortis Life Sciences Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Fortis Life Sciences Nanobody Discovery Service Product Portfolio
  48. 6.8.5 Fortis Life Sciences Recent Developments
  49. 6.9 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd.
  50. 6.9.1 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Company Information
  51. 6.9.2 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Business Overview
  52. 6.9.3 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Nanobody Discovery Service Product Portfolio
  54. 6.9.5 Three-Excellent Biological Pharmaceutical(Shanghai) Co., Ltd. Recent Developments
  55. 6.10 Biointron Biological Inc.
  56. 6.10.1 Biointron Biological Inc. Company Information
  57. 6.10.2 Biointron Biological Inc. Business Overview
  58. 6.10.3 Biointron Biological Inc. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Biointron Biological Inc. Nanobody Discovery Service Product Portfolio
  60. 6.10.5 Biointron Biological Inc. Recent Developments
  61. 6.11 SAFE Pharmaceutical Technology Co., Ltd.
  62. 6.11.1 SAFE Pharmaceutical Technology Co., Ltd. Company Information
  63. 6.11.2 SAFE Pharmaceutical Technology Co., Ltd. Business Overview
  64. 6.11.3 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 SAFE Pharmaceutical Technology Co., Ltd. Nanobody Discovery Service Product Portfolio
  66. 6.11.5 SAFE Pharmaceutical Technology Co., Ltd. Recent Developments
  67. 6.12 Abterra Biosciences
  68. 6.12.1 Abterra Biosciences Company Information
  69. 6.12.2 Abterra Biosciences Business Overview
  70. 6.12.3 Abterra Biosciences Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Abterra Biosciences Nanobody Discovery Service Product Portfolio
  72. 6.12.5 Abterra Biosciences Recent Developments
  73. 6.13 Chengdu Apak Biotechnology Co., Ltd.
  74. 6.13.1 Chengdu Apak Biotechnology Co., Ltd. Company Information
  75. 6.13.2 Chengdu Apak Biotechnology Co., Ltd. Business Overview
  76. 6.13.3 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Chengdu Apak Biotechnology Co., Ltd. Nanobody Discovery Service Product Portfolio
  78. 6.13.5 Chengdu Apak Biotechnology Co., Ltd. Recent Developments
  79. 6.14 ICarTab Biomedical Co., Ltd.
  80. 6.14.1 ICarTab Biomedical Co., Ltd. Company Information
  81. 6.14.2 ICarTab Biomedical Co., Ltd. Business Overview
  82. 6.14.3 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 ICarTab Biomedical Co., Ltd. Nanobody Discovery Service Product Portfolio
  84. 6.14.5 ICarTab Biomedical Co., Ltd. Recent Developments
  85. 6.15 Wuhan Daian Biotech Ltd
  86. 6.15.1 Wuhan Daian Biotech Ltd Company Information
  87. 6.15.2 Wuhan Daian Biotech Ltd Business Overview
  88. 6.15.3 Wuhan Daian Biotech Ltd Nanobody Discovery Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Wuhan Daian Biotech Ltd Nanobody Discovery Service Product Portfolio
  90. 6.15.5 Wuhan Daian Biotech Ltd Recent Developments
7 North America
  1. 7.1 North America Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Nanobody Discovery Service Market Size by Country (2021-2026)
  3. 7.3 North America Nanobody Discovery Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Nanobody Discovery Service Market Size by Country (2021-2026)
  3. 8.3 Europe Nanobody Discovery Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Nanobody Discovery Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Nanobody Discovery Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Nanobody Discovery Service Market Size by Country (2021-2026)
  3. 10.3 South America Nanobody Discovery Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Nanobody Discovery Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Nanobody Discovery Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Nanobody Discovery Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst